These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12957464)

  • 1. Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland.
    Wood R; Brewster DH; Fraser LA; Brown H; Hayes PC; Garden OJ
    Eur J Cancer; 2003 Sep; 39(14):2087-92. PubMed ID: 12957464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
    Khan SA; Emadossadaty S; Ladep NG; Thomas HC; Elliott P; Taylor-Robinson SD; Toledano MB
    J Hepatol; 2012 Apr; 56(4):848-54. PubMed ID: 22173164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.
    Taylor-Robinson SD; Toledano MB; Arora S; Keegan TJ; Hargreaves S; Beck A; Khan SA; Elliott P; Thomas HC
    Gut; 2001 Jun; 48(6):816-20. PubMed ID: 11358902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification.
    Walter D; Ferstl P; Waidmann O; Trojan J; Hartmann S; Schnitzbauer AA; Zeuzem S; Kraywinkel K
    Liver Int; 2019 Feb; 39(2):316-323. PubMed ID: 30176117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.
    Bertuccio P; Malvezzi M; Carioli G; Hashim D; Boffetta P; El-Serag HB; La Vecchia C; Negri E
    J Hepatol; 2019 Jul; 71(1):104-114. PubMed ID: 30910538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.
    Patel T
    Hepatology; 2001 Jun; 33(6):1353-7. PubMed ID: 11391522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptive epidemiology of cholangiocarcinoma in Italy.
    Alvaro D; Crocetti E; Ferretti S; Bragazzi MC; Capocaccia R;
    Dig Liver Dis; 2010 Jul; 42(7):490-5. PubMed ID: 20022823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan.
    Utada M; Ohno Y; Tamaki T; Sobue T; Endo G
    J Epidemiol; 2014; 24(3):193-9. PubMed ID: 24614916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of intrahepatic, perihilar, and distal cholangiocarcinoma in the French population.
    Al Mahjoub A; Bouvier V; Menahem B; Bazille C; Fohlen A; Alves A; Mulliri A; Launoy G; Lubrano J
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):678-684. PubMed ID: 30633038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of cancer of the liver and intrahepatic bile ducts in an Australian population.
    Luke C; Price T; Roder D
    Asian Pac J Cancer Prev; 2010; 11(6):1479-85. PubMed ID: 21338184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
    Jepsen P; Vilstrup H; Tarone RE; Friis S; Sørensen HT
    J Natl Cancer Inst; 2007 Jun; 99(11):895-7. PubMed ID: 17551150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
    Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
    Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.
    Saha SK; Zhu AX; Fuchs CS; Brooks GA
    Oncologist; 2016 May; 21(5):594-9. PubMed ID: 27000463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time and deprivation trends in incidence of primary liver cancer subtypes in England.
    Konfortion J; Coupland VH; Kocher HM; Allum W; Grocock MJ; Jack RH
    J Eval Clin Pract; 2014 Aug; 20(4):498-504. PubMed ID: 24902884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of cholangiocarcinoma.
    Shaib Y; El-Serag HB
    Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma: the "other" liver cancer on the rise.
    Davila JA; El-Serag HB
    Am J Gastroenterol; 2002 Dec; 97(12):3199-200. PubMed ID: 12492212
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical presentation and management of intrahepatic cholangiocarcinoma.
    Farges O; Fuks D
    Gastroenterol Clin Biol; 2010 Mar; 34(3):191-9. PubMed ID: 20202770
    [No Abstract]   [Full Text] [Related]  

  • 18. Changing pattern of epidemiology in intrahepatic cholangiocarcinoma.
    Njei B
    Hepatology; 2014 Sep; 60(3):1107-8. PubMed ID: 24327308
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic procedures and results in surgical therapy for cholangiocarcinoma].
    Schüle S; Altendorf-Hofmann AK; Knösel T; Uteß F; Settmacher U
    Zentralbl Chir; 2014 Dec; 139 Suppl 2():e25-34. PubMed ID: 22274918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.